
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1056 | 1012 | 1030 | 1218 | 1555 | 2381 |
Fund Return | 5.63% | 1.21% | 3.03% | 6.8% | 9.24% | 9.06% |
Place in category | 362 | 289 | 328 | 125 | 92 | 71 |
% in Category | 44 | 39 | 38 | 21 | 19 | 23 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Legal General US Index Trust C Acc | 3.34B | 4.50 | 15.58 | 15.55 | ||
Legal General US Index Trust C Dist | 776.28M | 4.51 | 15.59 | 15.55 | ||
Legal General US Index Trust I Acc | 1.54B | 27.16 | 11.15 | 15.07 | ||
Legal General US Index Trust I Dist | 1.6B | 27.16 | 11.15 | 15.07 | ||
Legal General US Index Trust F Acc | 515.94K | 4.46 | 15.26 | 15.22 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Janus Global Life Sciences Fund U G | 3.72B | 5.15 | 9.71 | 9.90 | ||
Wellington Global Health Care EquiG | 1.81B | 6.70 | 4.03 | 11.14 | ||
Adamant Medtech I GBP | 1.51B | 7.47 | 6.21 | 12.34 | ||
Global Health Care Fund W Acc GBP | 99.3M | 7.87 | 5.51 | 9.11 | ||
Pharmaceuticals Index Trust I Acc | 473.59M | 3.24 | 1.99 | 9.39 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Eli Lilly | US5324571083 | 8.51 | 818.22 | +1.61% | |
UnitedHealth | US91324P1021 | 6.47 | 523.20 | +0.02% | |
J&J | US4781601046 | 4.80 | 155.36 | +1.38% | |
AbbVie | US00287Y1091 | 4.32 | 205.19 | -0.52% | |
Novo Nordisk B | DK0062498333 | 3.68 | 466.4 | -0.05% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Strong Sell | Strong Sell | Neutral |
Technical Indicators | Strong Sell | Strong Sell | Strong Sell |
Summary | Strong Sell | Strong Sell | Sell |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review